Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Injunction Means Switches Have “Consequences,” Prosecutor Says

Executive Summary

The Medco injunction reflects the principle that pharmacy benefit management companies should be responsible for the "consequences" of therapeutic interchange, Associate U.S. Attorney James Sheehan said during a May 11 teleconference sponsored by Pharma Audioconferences
Advertisement

Related Content

PBM Disclosure Requirements On Rx Switches Likely To Increase Costs – FTC
PBM Disclosure Requirements On Rx Switches Likely To Increase Costs – FTC
Medco Contract With AIG Shows That “Transparency” Pays Off, PBM Says
Medco Contract With AIG Shows That “Transparency” Pays Off, PBM Says
PBM “Transparency” Defined In Medco Settlement
PBM “Transparency” Defined In Medco Settlement
IG Compliance Guide Will Change PBM Rebate Policies, AdvancePCS Says
Advertisement
UsernamePublicRestriction

Register

PS043978

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel